Melisa Göllü
Melisa Göllü
Melisa works as a legal assistant in our M&A Team. She first joined Hannes Snellman as a legal assistant trainee in 2022.
Melisa holds a bachelor’s degree in business administration from Haaga-Helia University of Applied Sciences.
References
Parties
Faron Pharmaceuticals Ltd
Transaction
Hannes Snellman acted as counsel to Faron Pharmaceuticals Ltd in its public share offering of EUR 30.7 million and the preceding issuance of convertible capital loans in the total amount of EUR 3.2 million and a private placement of EUR 4.8 million. Faron Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing treatment of cancers via novel immunotherapies. Faron’s shares are listed on Nasdaq First North Growth Market Finland and as depositary interests, representing entitlements to shares, on AIM in the United Kingdom. The offering consisted of a public offering to private individuals and legal entities in Finland and an institutional offering to institutional investors internationally, and a separate open offer to qualifying holders of depositary interests in the United Kingdom and elsewhere and a retail offer to retail investors in the United Kingdom.
Deal Value
EUR 30.7 million
Role
Counsel to Faron Pharmaceuticals Ltd
Parties
Sampo plc and Topdanmark A/S
Transaction
Sampo plc's recommended public exchange offer for the shares in Topdanmark A/S
Deal Value
DKK 33 billion
Role
Counsel to Sampo plc
Parties:
Uponor Corporation (target), Georg Fischer Ltd (buyer)
Transaction:
Counsel to Uponor Corporation in the recommended public cash tender offer by Georg Fischer Ltd to purchase all of the issued and outstanding shares of Uponor Corporation.
Value:
EUR 2.1 billion
Role:
Counsel to Uponor Corporation
Education and Professional Background
- Bachelor of Business Administration in Business Service Solutions and Languages, Haaga-Helia University of Applied Sciences, 2023
- Legal Assistant, Hannes Snellman 2023–
- Legal Assistant Trainee, Hannes Snellman 2022–2023